Basis
Commercial- Indications
- Cellular aging, NAD+ supplementation
Company intelligence / Profile preview
Elysium Health develops dietary supplements and consumer health products focused on healthy aging. Their flagship product Basis is clinically proven to increase NAD+ levels in humans. Other products target brain health, immune system function ("inflammaging"), skin/collagen maintenance, senescent cell clearance, and eye longevity. The company also offers Index—a direct-to-consumer epigenetic saliva test estimating biological age. Some products have been evaluated in placebo-controlled human trials for safety and efficacy[4][5][8].
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elysium Health.